Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-07-2249PMID 14504087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

  2003cited by this paper
• Hypermethylation of death‐associated protein (DAP) kinase CpG island is frequent not only in B‐cell but also in T‐ and natural killer (NK)/T‐cell malignancies

  2003cited by this paper
• Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications.

  2002cited by this paper
• Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor

  2002cited by this paper
• Cancer Epigenetics and Methylation

  2002cited by this paper
• Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001influential reference
• Methylation profiling in acute myeloid leukemia.

  2001cited by this paper
• DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer

  2001cited by this paper
• Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.

  2001cited by this paper
• THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES REPORT OF THE CLINICAL ADVISORY COMMITTEE MEETING

  2000cited by this paper
• The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

  2000cited by this paper
• The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.

  2000cited by this paper
• Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.

  2000cited by this paper
• Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

  2000cited by this paper
• ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.

  1999cited by this paper
• Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.

  1999influential reference
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• DAP kinase links the control of apoptosis to metastasis

  1997cited by this paper
• DNA methylation changes in hematologic malignancies: biologic and clinical implications.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.

  1996cited by this paper
• Morphology and classification of the myelodysplastic syndromes and their pathologic variants.

  1996cited by this paper
• Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure.

  1996cited by this paper
• Background and Objectives. Methylation of DNA is a

  year unknowncited by this paper

• From pathogenesis to management: therapy-related myeloid neoplasms in survivors of female-specific cancers

  2026cites this paper
• Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition

  2024cites this paper
• Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.

  2020cites this paper
• İnsan Hastalıklarında Epigenetiğin Rolüne Klinik Bakış

  2020cites this paper
• Characterization of secondary and therapy-related acute myeloid leukemia

  2020cites this paper
• ZNF382:a transcription inhibitor down-regulated in multiple tumors due to promoter methylation.

  2019cites this paper
• Precision medicine in the treatment stratification of AML patients: challenges and progress

  2018cites this paper
• [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].

  2017cites this paper
• Discovery of Novel and Selective DNA Methyltransferase 1 Inhibitors by Pharmacophore and Docking‐Based Virtual Screening

  2017cites this paper
• Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications.

  2016cites this paper
• ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells

  2016cites this paper
• Aberrant p 15 , p 16 , p 53 , and DAPK Gene Methylation in Myelomagenesis : Clinical and Prognostic Implications

  2016cites this paper
• A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers

  2016cites this paper
• Reprimo , is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia

  2015cites this paper
• Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia

  2015cites this paper
• tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia

  2015cites this paper
• Prognostic relevance of aberrant SOCS‐1 gene promoter methylation in myelodysplastic syndromes patients

  2015cites this paper
• Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia

  2015cites this paper
• Omeostasi dei telomeri nelle sindromi mielodisplastiche

  2014cites this paper
• Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma

  2014cites this paper
• Evaluating DAPK as a therapeutic target

  2014cites this paper
• Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients

  2014cites this paper
• DNA Methylation Abnormalities in Hematopoietic Disorders: Biological Significance and Methodological Approaches

  2014cites this paper
• Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes.

  2013cites this paper
• The myelodysplastic syndromes: diagnosis, prognosis and therapy

  2013cites this paper
• Epigenetic therapies in MDS and AML.

  2013cites this paper
• Identification of genetic aberrations in myelodysplastic syndromes

  2012cites this paper
• DNA methylation-based biomarkers in serum of patients with breast cancer.

  2012cites this paper
• DNA methylation in myelodysplastic syndrome DAP-kinase Low level of

  2012cites this paper
• Quantitative analyses of DAPK1 methylation in AML and MDS

  2012cites this paper
• Aberrant Methylation in Hematological Malignancies

  2012cites this paper
• Novel Targeted Therapeutics for Acute Myeloid Leukemia

  2012cites this paper
• Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid

  2011cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Perspectives Similarities and Differences between Therapy Leukemia

  2011cites this paper
• Aberrant Methylation of Death-Associated Protein Kinase 1 CpG Islands in Myelodysplastic Syndromes

  2011cites this paper
• Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring

  2011cites this paper
• Le sindromi mielodisplastiche: diagnosi, prognosi e terapia

  2011cites this paper
• Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.

  2010cites this paper
• Decitabine in the treatment of myelodysplastic syndromes

  2010cites this paper
• Epigenetic changes in the myelodysplastic syndrome.

  2010cites this paper
• Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.

  2010cites this paper
• Epigenetic changes in therapy-related MDS/AML.

  2010cites this paper
• Epigenetic therapy in myelodysplastic syndromes

  2010cites this paper
• DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.

  2010cites this paper
• Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome

  2010cites this paper
• ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.

  2010cites this paper
• Integrative Meta-Analysis of Differential Gene Expression in Acute Myeloid Leukemia

  2010cites this paper
• Analysis of genome-wide methylation and gene expression induced by 5-aza-2′-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia

  2010cites this paper
• Death-Associated Protein Kinase is Underexpressed in High-Grade Oral Squamous Cell Carcinoma

  2010cites this paper
• Blood Cells, Molecules, and Diseases

  2010cites this paper
• PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment.

  2009cites this paper
• Aberrant methylation of the death‐associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia

  2009cites this paper
• Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.

  2008cites this paper
• Epigenetics in acute myeloid leukemia.

  2008cites this paper
• Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias

  2008cites this paper
• DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function

  2008cites this paper
• The death‐associated protein kinase 2 is up‐regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells

  2007cites this paper
• Treatment Options in Advanced Myelodysplastic Syndrome, with Emphasis on Epigenetic Therapy

  2007cites this paper
• DNA Demethylating Agents and Histone Deacetylase Inhibitors in Hematologic Malignancies

  2007cites this paper
• Malignant Lymphomas

  2006cites this paper
• Clinical implications of SOCS1 methylation in myelodysplastic syndrome

  2006cites this paper
• Methylation and myelodysplastic syndromes: when and where?

  2006cites this paper
• DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma.

  2006cites this paper
• The genetics of the myelodysplastic syndromes: Classical cytogenetics and recent molecular insights

  2006cites this paper
• CpG Island Methylator Phenotype and Childhood Leukemia

  2006cites this paper
• DNA methylation and apoptosis.

  2006cites this paper
• Clinical implications of SOCS1 methylation in myelodysplastic

  2006cites this paper
• Untersuchungen zur aberranten DNA-Methylierung in humanen myeloischen Neoplasien mit Hilfe hochauflösender quantitativer Analysemethoden

  2006cites this paper
• Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

  2006cites this paper
• Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.

  2005cites this paper
• Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.

  2005influential citation
• Clinical development of decitabine as a prototype for an epigenetic drug program.

  2005cites this paper
• The silence of the genes: epigenetic disturbances in haematopoietic malignancies

  2005cites this paper
• Carcinogenesis, cancer therapy and chemoprevention

  2005cites this paper
• Hypermethylation of the suppressor of cytokine signalling‐1 (SOCS‐1) in myelodysplastic syndrome

  2005cites this paper
• Profile of azacitidine

  2005cites this paper
• Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences

  2005cites this paper
• Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients

  2005cites this paper
• Low level of DAP-kinase DNA methylation in myelodysplastic syndrome.

  2004cites this paper
• Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome.

  2004cites this paper
• Epigenetic Inactivation of Tumor Suppressor Genes in Hematologic Malignancies

  2004cites this paper
• Models of granulocyte DNA structure are highly predictive of myelodysplastic syndrome.

  2004cites this paper
• Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia

  2004cites this paper
• Aberrant DNA methylation and synthesis in radiation-induced genetic instability and radiation leukaemogenesis

  2004cites this paper
• A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.

  2004cites this paper
• Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia

  2004influential citation
• DNA‐methylation analysis identifies the E‐cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies

  2004cites this paper